Posts

Shionogi Announces Supplemental Approval in Japan for Pediatric Dosage and Administration of XOCOVA to Treat COVID-19

Shionogi's COVID Antiviral Xocova Approved by FDA as Post‑Exposure Preventive for COVID-19 in the U.S.

Live Friday: CDC Ends Universal COVID-19 Vaccine Recommendation – Anti-Vax Shift Under RFK Jr.?

CHMP Recommends Moderna's mCombriax Flu-COVID Vaccine for Adults 50+

N.Y. Attorney General Sues Former Emergent BioSolutions CEO Robert Kramer for Insider Trading

FDA Commissioner Makary Addresses COVID-19 Vaccine Safety Concerns Amid Internal Debates and Investigations

CDC highlights strong effectiveness of 2024–2025 COVID-19 shots in kids while FDA reviews reports of alleged post-vaccination deaths

FDA Broadens COVID-19 Vaccine Safety Probe to Adults Under New Health Leadership

FDA names Tracy Beth Heg as acting CDER chief

FDA Refuses to Release Detailed Data on Claimed COVID Vaccine-Linked Child Deaths in Near Term

Recent Developments on Vinay Prasad's Leaked FDA Memo, Alzheimer's Disease Updates, and Next-Gen Obesity Drugs

FDA's Vinay Prasad Links 10 Child Deaths to COVID-19 Vaccines, Calls for Stricter Review Guidelines

Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx PCR Platform to Support Submission to the U.S. FDA

Pfizer Cuts 11 R&D Programs amid Ongoing Revenue Declines and Cost Realignment Efforts

CDC Updates COVID-19 and Chickenpox Vaccine Guidance Based on ACIP Recommendations

CDC Advisors Shift COVID-19 Vaccine Guidance to Individual Decision-Making

RFK Jr. Names 8 New ACIP Members, Replacing Prior Committee Before Key Vaccine Votes

RFK Jr. Blasts Pharma Industry and Spreads mRNA Vaccine Misinformation During Heated Senate Hearing

Vinay Prasad Details New Approach to COVID-19 Vaccine Approvals in Recent FDA Memos

FDA Approves Updated COVID-19 Shots from Pfizer, Moderna, Novavax with New Restrictions